FEM
AMED

Fulcrum Equity Management’s Amedisys AMED Stock Holding History

Fulcrum Equity Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,145
Closed -$1.26M – 181
2021
Q2 		$1.26M Sell
5,145
-1,555
-23% -$408K 0.47% 65
2021
Q1 		$1.77M Buy
+6,700
New +$1.89M 0.7% 52

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fulcrum Equity Management's AMED Position: Q3 2021 in Review

Fulcrum Equity Management sold out of Amedisys (AMED) in Q3 2021, closing a stake of 5,145 shares — an estimated $1.26M sold.

Fulcrum Equity Management first reported a position in AMED in Q1 2021 and held it in 2 quarters. The position peaked at $1.77M in Q1 2021. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Fulcrum Equity Management reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Fulcrum Equity Management sold 5,145 Amedisys shares in Q3 2021, an estimated $1.26M.
  • Fulcrum Equity Management first reported a position in Amedisys in Q1 2021 and held it in 2 quarters.
  • Fulcrum Equity Management's Amedisys position peaked at $1.77M in Q1 2021.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Fulcrum Equity Management's 13F filing for Q3 2021, filed 25 Jan 2022.